PAG, an Asia-focussed personal fairness agency, together with its consortium companions CX Partners and Samara Capital, is all set to acquire a controlling stake in Anjan Drug Pvt. Ltd, a Chennai-based producer of energetic pharmaceutical elements (API).
However, the phrases of the deal weren’t disclosed.
The acquisition is a part of the PAG-led consortium’s technique to create a platform for the event and manufacturing of bulk drug elements, PAG stated in an announcement.
“We see the Indian API market as a very attractive opportunity and well-positioned for the future,” stated Nikhil Srivastava, managing director and head, India personal fairness, PAG.